Findings
Background
Patients and methods
Results
Factor | SATB1 expresssion |
---|---|
Age
| |
R | 0.044 |
p | 0.603 |
n | 143 |
Differentiation grade
| |
R | −0.223 |
p | 0.006** |
n | 151 |
Clinical stage
| |
R | −0.039 |
p | 0.651 |
n | 139 |
Ki67
| |
R | −0.025 |
p | 0.764 |
n | 149 |
AR
| |
R | 0.003 |
p | 0.973 |
n | 151 |
ER
| |
R | −0.072 |
p | 0.388 |
n | 145 |
PR
| |
R | 0.060 |
p | 0.469 |
n | 146 |
DACH2
| |
R | 0.280 |
p | 0.001** |
n | 143 |
RBM3
| |
R | −0.092 |
p | 0.263 |
n | 149 |
Chek1
| |
R | 0.079 |
p | 0.353 |
n | 139 |
pChek1
| |
R | 0.260 |
p | 0.002* |
n | 139 |
Chek2
| |
R | 0.079 |
p | 0.344 |
n | 144 |
pChek2
| |
R | 0.130 |
p | 0.125 |
n | 141 |
MCM3
| |
R | 0.172 |
p | 0.042* |
n | 140 |
Ovarian cancer specific survival | 5-year overall survival | |||||
---|---|---|---|---|---|---|
HR(95%CI) |
p-value
|
n(events)
| HR(95%CI) |
p-value
|
n(events)
| |
Univariable
|
Univariable
| |||||
SATB1 neg | 1.00 | 0.005 | 87(67) | 1,00 | 0.017 | 87(60) |
SATB1 pos | 2.14(1.26-3.62) | 18(18) | 1.96(1.13-3.42) | 18(16) | ||
Multivariable
|
Multivariable
| |||||
SATB1 neg | 1.00 | 0.009 | 82(62) | 1,00 | 0.022 | 82(55) |
SATB1 pos | 2.20(1.21-3.99) | 14(14) | 2.06(1.11-3.81) | 14(13) |